The cytotoxic effects of NKEVs were shown to be partly abolished by antibodies against Fas or Fas ligand (FasL), suggesting that ligand–receptor interaction is another mechanism by which NKEVs are targeted to tumor cells (6, 8), although this has yet to be demonstrated experimentally. Here, FASLG is linked to neoplasm.